For patients with impairment on the G8, the median OS was 6.8 months (95% CI, 2.4-10.1), compared with 14 months (95% CI, 9.9-not evaluable; P =.0110) for patients without impairment on the G8. Use of ...

Treatment and outcomes of bladder cancer in Armenia. † The MVA was built by controlling for age, race, sex, smoking status, baseline BMI, prior lines of therapy (#), and # of metastatic sites. This is ...

A Call for Improving the Quality of Cancer Care in Geriatric Patients A review of geriatric assessment tools and their role in assessing older patients with cancer before and after treatment. For many ...

Geriatric assessment tools, including CGA, offer superior prognostic value over traditional performance measures in older DLBCL patients. Comprehensive geriatric assessments reveal frailty levels, ...

Real-world immunotherapy biomarker testing patterns and results for patients with advanced gastroesophageal cancers in the United States. This is an ASCO Meeting Abstract from the 2022 ASCO ...

At all resource levels, Soto says, “we recommended using at least a brief geriatric screening tool” – a widely used questionnaire called the G8 – “and for patients who are identified as vulnerable, we ...

A free tool aims to increase oncologists’ use of formal geriatric assessments (GAs) in older patients with cancer. Such assessments seek to measure factors beyond age that can affect a patient’s risk ...